FDA approval
FDA approval
Merck’s $10B Deal and Breakthroughs in Hearing Restoration!
🌟 Merck acquires Verona for $10B! 🧬 Virtual Cell Challenge launched! 👂 Gene therapy shows promise for restoring hearing! 🔍 Fujifilm rebrands! 📅 BIO 2025 highlights!
Revolutionizing Protein Production: Greener Cheaper Solutions!
🌱 Discover how molecular farming uses plants to produce proteins, offering lower costs and a greener footprint in biopharmaceuticals! 🌍💡🚀
EMA Approves 10 New Life-Changing Medicines!
📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉
Revolutionizing Cell and Gene Therapy: A Vital Call to Unify
📰 FDA approval of gene therapy & increase in activity highlight need for standardized cell & gene therapy hub. Collaboration is crucial. 💡🤝
FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!
📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩🔬🔬🧪🗂 CAR-T FDA
SynaptixBio Receives FDA ODD for Leukodystrophy Treatment
📰 Rare disease specialist SynaptixBio Ltd receives FDA ODD for TUBB4A leukodystrophy, allowing research on therapy for isolated hypomyelination. 💊💡✨
FDA Approves Game-Changing Solid Tumor Cell Therapy!
🚀 Iovance receives FDA approval for groundbreaking solid tumor cell therapy! 💪🔬 Stay tuned for more exciting updates! 🌟
Biogen Pulls Plug on Controversial Alzheimer’s Drug
📢 Biogen discontinues controversial Alzheimer's drug Aduhelm amid mounting criticism and lack of evidence. 💊❌👥
